The study by Miuro et al. showed elevated omentin-1 levels in SSc patients with increased right ventricle systolic pressure RVSP, which may be associated with a loss of response to the vasodilating effect of omentin-1 caused by eNOS suppression in epigenetic mechanisms or a compensatory increase in omentin-1 levels. This evidence concerns the gene NOS3 and systemic sclerosis.